|
Market Closed -
Nasdaq
01:00:00 06/01/2026 +04
|
5-day change | 1st Jan Change | ||
| 4.660 USD | -0.21% |
|
-.--% | +3.10% |
| 04-15 | Evotec Taps CureVac Executive as COO | MT |
| 01-06 | CureVac ends coverage after BioNTech acquisition |  |
| Market Cap | 867M 1.01B 821M 744M 1.4B 96.12B 1.4B 9.75B 3.75B 48.9B 3.78B 3.7B 155B | P/E 2023 |
-3.23x | P/E 2024 | 4.57x |
|---|---|---|---|---|---|
| Enterprise Value | 424M 492M 402M 364M 683M 47.02B 686M 4.77B 1.83B 23.92B 1.85B 1.81B 75.6B | EV / Sales 2023 |
9.16x | EV / Sales 2024 | 0.55x |
| Free-Float |
-
| Yield 2023 * |
-
| Yield 2024 | - |
Last Transcript : CureVac
| 1 day | -0.21% | ||
| Current year | +3.10% |
| Current year | 4.48 |  | 4.68 |
| 1 year | 4 | | 5.55 |
| 3 years | 2.22 | | 8.25 |
| 5 years | 2.22 | | 65.39 |
| 10 years | 2.22 | | 151.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 28/03/2023 | |
Myriam Mendila
CTO | Chief Tech/Sci/R&D Officer | 60 | - |
Malte Greune
COO | Chief Operating Officer | 61 | 01/07/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 01/08/2015 | |
Mathias Hothum
BRD | Director/Board Member | 58 | 01/08/2015 |
| Director/Board Member | 69 | 22/06/2022 |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 53.76M 62.39M 50.9M 46.14M 86.56M 5.96B 86.99M 605M 232M 3.03B 234M 229M 9.58B | 535M 621M 507M 459M 862M 59.34B 866M 6.02B 2.31B 30.19B 2.33B 2.28B 95.4B |
| Net income | -260M -302M -246M -223M -419M -28.85B -421M -2.93B -1.13B -14.68B -1.13B -1.11B -46.38B | 162M 188M 154M 139M 261M 17.98B 262M 1.82B 701M 9.15B 707M 691M 28.91B |
| Net Debt | -361M -419M -341M -310M -581M -39.99B -584M -4.06B -1.56B -20.34B -1.57B -1.54B -64.28B | -443M -514M -419M -380M -713M -49.1B -717M -4.98B -1.91B -24.98B -1.93B -1.89B -78.93B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CVAC Stock
Select your edition
All financial news and data tailored to specific country editions
